While eliminated in the United States, rubella virus remains an endemic threat in many countries globally, with five of six WHO regions establishing rubella elimination goals. Nanotrap® Microbiome A Particles offer an automated method for non-invasive surveillance of the virus, allowing health officials to access risk and further the goal of elimination within endemic areas. In This Experiment The Nanotrap Microbiome A Particles were evaluated for efficient capture of rubella

Article titled: Leveraging artificial intelligence community analytics and nanopore metagenomic surveillance to monitor early enteropathogen outbreaks, where Nanotrap Microbiome B Particle Technology is used to capture and concentrate the total bacterial biomass.

Our team partners with labs at every stage—from concept to confidence—to help accelerate scientific impact. Inside, you’ll find an overview of how we support researchers with: Customized laboratory design Product selection guidance Method development and implementation training Workflow optimization to boost performance and reproducibility You’ll also meet our incredible Field Applications team, who bring deep expertise across proteomics, liquid biopsy, infectious disease, ex